Send feedback

LIG4 p.Pro809Ala

c.2425C>G · rs137899041 · VCV647972

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 4 submitters
AlphaMissense
likely benign
0.0862 · ACMG-weighted
gnomAD v4.1
Rare
ultra-rare (popmax 0.0329%, mid)
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
severe combined immunodeficiency due to DCLRE1C deficiency

Computational evidence

Protein change
AlphaMissense0.0862likely benign
REVEL0.237benign-leaning
SaProtLLR -7.41tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 8.6GERP 1.9, phastCons 1
Regional constrainto/e 1.01unconstrained · MANE · 1,269 bp · p 0.81 · regional, not allelic
Overall
CADD21.5PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0329% Middle Eastern · 2/6,084 alleles
Filtering AF 0.0058% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0038%
Overall 0.00551% 89/1,613,956 alleles · ultra-rare exomes 79/1,461,812 · genomes 10/152,144 · joint denominator
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0912% 1,096
Middle Easterngrpmax 0.0329% 3,042
Admixed American 0.0117% 8,571
Remaining individualsnot grpmax-eligible 0.0112% 8,926
European (non-Finnish) 0.00381% 26,223
African / African-American 0.00134% 74,892

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
LIG4
Protein
p.Pro809Ala
Coding
c.2425C>G
MANE Select
NM_206937
dbSNP
rs137899041
Type
single nucleotide variant
Location
chr13:108208844 (GRCh38)
Gene constraint
LOEUF 1.043 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
Structure
AlphaFold pLDDT 88.44 · 32 PDB
Residue 809
an α-helix; the brct 2 domain; a UniProt-annotated variant site (in lig4s)
Full LIG4 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

severe combined immunodeficiency due to DCLRE1C deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: DNA ligase IV deficiency

For Severe combined immunodeficiency due to DCLRE1C deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/lig4-p-pro809ala (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown